vs
Side-by-side financial comparison of Lifeway Foods, Inc. (LWAY) and VIEMED HEALTHCARE, INC. (VMD). Click either name above to swap in a different company.
VIEMED HEALTHCARE, INC. is the larger business by last-quarter revenue ($76.2M vs $55.4M, roughly 1.4× Lifeway Foods, Inc.). VIEMED HEALTHCARE, INC. runs the higher net margin — 7.4% vs 4.6%, a 2.8% gap on every dollar of revenue. On growth, VIEMED HEALTHCARE, INC. posted the faster year-over-year revenue change (25.5% vs 18.0%). VIEMED HEALTHCARE, INC. produced more free cash flow last quarter ($9.7M vs $-17.4M). Over the past eight quarters, VIEMED HEALTHCARE, INC.'s revenue compounded faster (22.7% CAGR vs 11.4%).
Lifeway Foods is an Illinois-based health food company founded in 1986. They are a leading U.S. supplier of kefir and fermented probiotic products to support the microbiome.
Viemed Healthcare, Inc. is a medical technology firm specializing in respiratory care solutions. It develops, manufactures and distributes portable ventilators, respiratory therapy devices and related support services, catering to acute care, post-acute care and home care segments across North America, Europe and key Asia-Pacific markets for patients with respiratory conditions.
LWAY vs VMD — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $55.4M | $76.2M |
| Net Profit | $2.5M | $5.6M |
| Gross Margin | 27.8% | 57.9% |
| Operating Margin | 6.8% | 11.0% |
| Net Margin | 4.6% | 7.4% |
| Revenue YoY | 18.0% | 25.5% |
| Net Profit YoY | 1688.1% | 30.7% |
| EPS (diluted) | $0.15 | $0.14 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $55.4M | $76.2M | ||
| Q3 25 | $57.1M | $71.9M | ||
| Q2 25 | $53.9M | $63.1M | ||
| Q1 25 | $46.1M | $59.1M | ||
| Q4 24 | $46.9M | $60.7M | ||
| Q3 24 | $46.1M | $58.0M | ||
| Q2 24 | $49.2M | $55.0M | ||
| Q1 24 | $44.6M | $50.6M |
| Q4 25 | $2.5M | $5.6M | ||
| Q3 25 | $3.5M | $3.5M | ||
| Q2 25 | $4.2M | $3.2M | ||
| Q1 25 | $3.5M | $2.6M | ||
| Q4 24 | $-160.0K | $4.3M | ||
| Q3 24 | $3.0M | $3.9M | ||
| Q2 24 | $3.8M | $1.5M | ||
| Q1 24 | $2.4M | $1.6M |
| Q4 25 | 27.8% | 57.9% | ||
| Q3 25 | 28.7% | 57.5% | ||
| Q2 25 | 28.6% | 58.3% | ||
| Q1 25 | 23.9% | 56.3% | ||
| Q4 24 | 25.3% | 59.5% | ||
| Q3 24 | 25.7% | 59.3% | ||
| Q2 24 | 27.0% | 59.8% | ||
| Q1 24 | 25.8% | 58.9% |
| Q4 25 | 6.8% | 11.0% | ||
| Q3 25 | 8.8% | 7.8% | ||
| Q2 25 | 10.8% | 8.1% | ||
| Q1 25 | 3.4% | 6.5% | ||
| Q4 24 | 1.5% | 10.6% | ||
| Q3 24 | 9.1% | 9.7% | ||
| Q2 24 | 11.0% | 6.6% | ||
| Q1 24 | 8.0% | 4.4% |
| Q4 25 | 4.6% | 7.4% | ||
| Q3 25 | 6.2% | 4.9% | ||
| Q2 25 | 7.9% | 5.0% | ||
| Q1 25 | 7.7% | 4.4% | ||
| Q4 24 | -0.3% | 7.1% | ||
| Q3 24 | 6.5% | 6.7% | ||
| Q2 24 | 7.7% | 2.7% | ||
| Q1 24 | 5.4% | 3.2% |
| Q4 25 | $0.15 | $0.14 | ||
| Q3 25 | $0.23 | $0.09 | ||
| Q2 25 | $0.28 | $0.08 | ||
| Q1 25 | $0.23 | $0.06 | ||
| Q4 24 | $0.00 | $0.10 | ||
| Q3 24 | $0.19 | $0.10 | ||
| Q2 24 | $0.25 | $0.04 | ||
| Q1 24 | $0.16 | $0.04 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $5.6M | $13.5M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $85.8M | $141.5M |
| Total Assets | $105.6M | $199.2M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $5.6M | $13.5M | ||
| Q3 25 | $23.0M | $11.1M | ||
| Q2 25 | $21.2M | $20.0M | ||
| Q1 25 | $19.4M | $10.2M | ||
| Q4 24 | $16.7M | $17.5M | ||
| Q3 24 | $20.6M | $11.3M | ||
| Q2 24 | $14.6M | $8.8M | ||
| Q1 24 | $12.0M | $7.3M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $2.5M | — |
| Q4 25 | $85.8M | $141.5M | ||
| Q3 25 | $82.8M | $133.6M | ||
| Q2 25 | $78.7M | $139.7M | ||
| Q1 25 | $74.2M | $134.8M | ||
| Q4 24 | $71.9M | $131.4M | ||
| Q3 24 | $71.5M | $125.0M | ||
| Q2 24 | $68.0M | $119.4M | ||
| Q1 24 | $63.5M | $116.3M |
| Q4 25 | $105.6M | $199.2M | ||
| Q3 25 | $109.5M | $202.4M | ||
| Q2 25 | $98.3M | $184.6M | ||
| Q1 25 | $93.7M | $178.1M | ||
| Q4 24 | $90.5M | $177.1M | ||
| Q3 24 | $91.3M | $169.5M | ||
| Q2 24 | $84.9M | $163.9M | ||
| Q1 24 | $82.8M | $154.9M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 0.04× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $267.0K | $18.4M |
| Free Cash FlowOCF − Capex | $-17.4M | $9.7M |
| FCF MarginFCF / Revenue | -31.5% | 12.7% |
| Capex IntensityCapex / Revenue | 31.9% | 11.5% |
| Cash ConversionOCF / Net Profit | 0.11× | 3.27× |
| TTM Free Cash FlowTrailing 4 quarters | $-16.4M | $11.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $267.0K | $18.4M | ||
| Q3 25 | $6.9M | $18.4M | ||
| Q2 25 | $3.9M | $12.3M | ||
| Q1 25 | $-150.0K | $2.9M | ||
| Q4 24 | $-2.6M | $15.0M | ||
| Q3 24 | $7.5M | $12.7M | ||
| Q2 24 | $6.5M | $10.2M | ||
| Q1 24 | $1.5M | $1.2M |
| Q4 25 | $-17.4M | $9.7M | ||
| Q3 25 | $1.8M | $10.7M | ||
| Q2 25 | $1.6M | $4.1M | ||
| Q1 25 | $-2.4M | $-12.6M | ||
| Q4 24 | $-3.8M | $3.2M | ||
| Q3 24 | $5.9M | $1.7M | ||
| Q2 24 | $5.1M | $1.2M | ||
| Q1 24 | $-923.0K | $-4.8M |
| Q4 25 | -31.5% | 12.7% | ||
| Q3 25 | 3.1% | 14.9% | ||
| Q2 25 | 3.0% | 6.5% | ||
| Q1 25 | -5.1% | -21.4% | ||
| Q4 24 | -8.2% | 5.2% | ||
| Q3 24 | 12.8% | 3.0% | ||
| Q2 24 | 10.4% | 2.3% | ||
| Q1 24 | -2.1% | -9.5% |
| Q4 25 | 31.9% | 11.5% | ||
| Q3 25 | 9.0% | 10.6% | ||
| Q2 25 | 4.3% | 12.9% | ||
| Q1 25 | 4.8% | 26.2% | ||
| Q4 24 | 2.7% | 19.5% | ||
| Q3 24 | 3.3% | 19.0% | ||
| Q2 24 | 2.9% | 16.3% | ||
| Q1 24 | 5.5% | 11.9% |
| Q4 25 | 0.11× | 3.27× | ||
| Q3 25 | 1.96× | 5.23× | ||
| Q2 25 | 0.92× | 3.88× | ||
| Q1 25 | -0.04× | 1.09× | ||
| Q4 24 | — | 3.47× | ||
| Q3 24 | 2.50× | 3.29× | ||
| Q2 24 | 1.73× | 6.94× | ||
| Q1 24 | 0.64× | 0.73× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
LWAY
| Drinkable Kefirotherthan Pro Bugs | $47.8M | 86% |
| Cheese | $4.7M | 8% |
| Cream And Other | $1.7M | 3% |
| Other | $1.2M | 2% |
VMD
Segment breakdown not available.
